A one-year, placebo-controlled trial of oral nicotinamide (vitamin B3) therapy by the University of Sydney did not lead to lower rates of skin cancer in organ transplant recipients. The result is in striking contrast to a ...
Fewer cases of melanoma were observed in people with a history of atopic diseases, such as allergic asthma or rhinitis, than in nonatopic people. The risk of melanoma in people with atopy was up to 50% lower than in the control ...
Mar 6, 2023
0
3
In patients with a poorly functioning tricuspid valve in the heart, a minimally invasive procedure using a clip to repair the valve was safe and improved both the valve's functioning and patients' quality of life at one year ...
Mar 6, 2023
0
4
Colorectal cancer is the second-leading cause of cancer death in the U.S. The U.S. Preventive Services Task Force and the Multi-Society Task Force on colon cancer encourage patients to start screening at age 50 unless they ...
Mar 2, 2023
0
3
Among children undergoing needle-related procedures, providing procedural information and distraction using immersive virtual reality (IVR) significantly reduces pain and anxiety, according to a study published online Feb. ...
Mar 1, 2023
0
2
Remdesivir was one of the first medications approved for treatment of COVID-19. Clinical studies evaluated its effectiveness, but did not generate conclusive results. A new analysis of the study data shows that a specific ...
Feb 22, 2023
1
24
For patients with metastatic castration-resistant prostate cancer (mCRPC), treatment with talazoparib (TALA) plus enzalutamide (ENZA) is better than placebo (PBO) plus ENZA, according to a study presented at the American ...
Feb 17, 2023
0
3
Patients are often asked to rate their feelings using a rating scale, when talking to psychologists or doctors about their mental health. This is currently how depression and anxiety are diagnosed. However, a new study from ...
Feb 16, 2023
0
23
High-dose oral vitamin D reduced skin inflammation and increased immunoprotection in patients with chemical-induced skin rashes, according to findings from a recent Northwestern Medicine clinical trial published in JCI Insight.
Feb 15, 2023
0
37
Nightly use of 0.05 percent atropine eye drops compared with placebo results in a significantly lower incidence of myopia and a lower percentage of patients with fast myopic shift at two years among children aged 4 to 9 years ...
Feb 14, 2023
0
6
